6-K//Foreign company update
Altamira Therapeutics Ltd. 6-K
Accession 0001213900-25-041560
$CYTOFCIK 0001601936other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:30 PM ET
Size
2.6 MB
Accession
0001213900-25-041560
Documents
- 6-Kea0241380-6k_altamira.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
- EX-99.1ea024138001ex99-1_altamira.htm
NOTICE TO SHAREHOLDERS DATED MAY 9, 2025
- EX-99.2ea024138001ex99-2_altamira.htm
PROXY CARD FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
- EX-99.3ea024138001ex99-3_altamira.htm
NOTICE OF INTERNET AVAILABILITY
- GRAPHICex99-1_001.jpg
GRAPHIC
- GRAPHICex99-2_001.jpg
GRAPHIC
- GRAPHICex99-2_002.jpg
GRAPHIC
- GRAPHICex99-3_001.jpg
GRAPHIC
- GRAPHICex99-3_002.jpg
GRAPHIC
Issuer
Altamira Therapeutics Ltd.
CIK 0001601936
Entity typeother
IncorporatedBermuda
Related Parties
1- filerCIK 0001601936
Filing Metadata
- Form type
- 6-K
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:30 PM ET
- Size
- 2.6 MB